Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BlueCheck for Early Enamel Lesion Detection
NCT07819370Phase 4Not yet recruiting
- Sponsor
- Colgate-Palmolive
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Colgate-Palmolive. Primary endpoint: Enamel Lesions per BlueCheck at 12 weeks. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07819370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07819370.